NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's cash flow from others for the three months ended in Sep. 2016 was $1,062 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2016 was $1,571 Mil.
Novo Nordisk A/S Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2016 was 159.346271706 (Dec. 2015 ) + 140.626399546 (Mar. 2016 ) + 208.880833711 (Jun. 2016 ) + 1062.05753879 (Sep. 2016 ) = $1,571 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Novo Nordisk A/S Annual Data
|Cash Flow from Others||31||-102||243||458||364||139||-441||-402||589||383|
Novo Nordisk A/S Quarterly Data
|Cash Flow from Others||413||664||-53||-518||475||292||159||141||209||1,062|